by Kayla Mossien | Oct 4, 2021 | News
Most people have never heard of causal learning, but the concept is an important one for the future of healthcare because it holds the key to understanding and fighting disease and improving outcomes. However, to understand how and why causality is so important in the...
by Kayla Mossien | Apr 15, 2021 | News
Pharmaceutical Executive reporter discusses how a coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction. Read the full story here.
by Simona Gilman | Jul 20, 2020 | News
Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here.
by Simona Gilman | Jul 17, 2020 | News
Myeloma Research News covers GNS launch of Gemini. Read more here.
by Simona Gilman | Jul 8, 2020 | News
This is the first AI-based virtual patient for multiple myeloma, said Colin Hill, the Cambridge, Mass.-based company’s co-founder and chief executive. It is traditionally difficult to predict how specific drugs or combinations of drugs might help individual multiple...
by wpengine | Jan 8, 2020 | Featured Posts, News
Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia’s Medicare Advantage population that could benefit from an extra layer of support. Read the full article...
